Results 41 to 50 of about 17,345 (219)

DYSGEUSIA-A REVIEW [PDF]

open access: yes, 2013
Dysgeusia, is distortion of the sense of taste.  It is an abnormality in patient ability to detect the four standard taste stimuli (salt, sweat, sour, bitter) or electric stimuli (electrogustometry).
M.SUBHA, VELMURUGAN
core   +1 more source

Management of Dysgeusia related to Cancer [PDF]

open access: yes, 2017
Introduction: Taste change due to cancer is a notorious side effect, adversely affecting appetite and weight. Even though taste change or dysgeusia is one of the major causes of poor nutritional status in cancer survivors, it is not addressed as a ...
DURGESHWORI MUNANKARMI   +1 more
core   +1 more source

Exploring the impact of dysgeusia on sensory perception, appetite, and texture during oral nutritional supplement consumption in head and neck cancer and multiple myeloma patients

open access: yesClinical Nutrition Open Science
SUMMARY: Dysgeusia, an altered taste perception commonly experienced by cancer patients undergoing chemotherapy or radiotherapy, significantly impacts their sensory perception, appetite, and compliance with oral nutritional supplements (ONS), essential ...
Ghias Kulsoom   +2 more
doaj   +1 more source

EARLY RESOLUTION OF TALQUETAMAB ORAL SIDE EFFECTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED WATERLESS EMPIRICAL TASTE TEST (WETT) AND PATIENT REPORTED OUTCOMES (PRO) DATA FROM TALISMAN

open access: yesHematology, Transfusion and Cell Therapy
Background: In the phase 1/2 MonumenTAL-1 study, talquetamab (Tal) achieved high response rates and durable survival in RRMM. Although taste changes and other oral toxicities are common, their longitudinal assessment remains limited.
Niels Wcj VAN DE DONK   +29 more
doaj   +1 more source

P47 | UTILITY AND SENSITIVITY OF WETT-SA53 TO MEASURE DYSGEUSIA ASSOCIATED WITH TALQUETAMAB, A GPRC5D×CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY DATA FROM THE TALISMAN STUDY

open access: yesHaematologica
Introduction. Talquetamab (Tal) is a GPRC5D×CD3 bispecific antibody approved for the treatment of relapsed/refractory multiple myeloma (RRMM). Early oral adverse event (AEs) onset, including dysgeusia, can impact patient (pt) quality of life.
R. Popat   +26 more
doaj   +1 more source

Reflex seizures and epilepsy surgery: A network approach case‐based exploration

open access: yesEpileptic Disorders, EarlyView.
Abstract Context Reflex seizures (RS) are defined by their consistent provocation by specific stimuli, encompassing a broad range from elementary sensory inputs to complex cognitive tasks. While RS are often encountered in clinical practice, their surgical management remains sparsely reported and poorly systematized.
Olivier Aron   +6 more
wiley   +1 more source

Carbonation dysgeusia associated with topiramate

open access: yesAmerican Journal of Health-System Pharmacy, 2020
AbstractPurposeA case of carbonation dysgeusia associated with the use of topiramate is reported in order to bring awareness to a lesser-known adverse effect of the medication so that providers may be able to more effectively counsel patients and provide potential solutions.SummaryA 39-year-old Caucasian woman with longstanding epilepsy was initiated ...
Maria, Charbonneau   +3 more
openaire   +2 more sources

Nutritional Management of Dysgeusia in the Oncology Patient [PDF]

open access: yes, 2023
Background Dysgeusia is a side effect of chemoradiation that currently has no standard intervention. The findings of this study are intended to improve the understanding of how to best treat dysgeusia to contribute to the prevention of malnutrition and ...
Wilson, Kara
core  

Twelve‐Month Outcomes of a Preventive Dysphagia Intervention in Patients With Head and Neck Cancer—A Randomized Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Radiation‐associated dysphagia is common after radiotherapy for head and neck cancer and may occur early or years later. The effect of preventive exercises might be undermined by poor adherence. Aim To evaluate the effect of a simple preventive exercise protocol on swallowing function up to 12 months after radiotherapy.
Kerstin Petersson   +4 more
wiley   +1 more source

Associations of anti-SARS-CoV-2 antibody levels with any chronic COVID-19 symptom, particularly chronic fatigue, anosmia and dysgeusia.

open access: yes, 2022
Associations of anti-SARS-CoV-2 antibody levels with any chronic COVID-19 symptom, particularly chronic fatigue, anosmia and dysgeusia.
Jason Zimmerman (13200084)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy